Shared decision making with brain tumor patients

Improving shared decision-making for patients with brain tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON23658

Enrollment

300

Registered

2021-02-08

Start date

2021-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients with meningioma (50%) or low- (20%) or high-grade (30%) glioma.

Interventions

In the first year of the study, patients will receive care as usual. From the second year onwards, we will implement the scientifically developed Goings-On app in clinical practice to identify individ

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study a participant must meet all of the following criteria: 1) Adult patients (>18 years of age) with meningioma or low- or high-grade glioma who visit the neurosurgical clinic and (from the second year onwards) who are willing and able to use the Goings-On application. 2) Fluent in Dutch.

Exclusion criteria

Exclusion criteria: 1) Being a participant in another clinical study that may induce potential contamination of the effects of the other study. 2) Unable physically and/or mentally to fill out the app on a daily basis (a minute a day) and/or fill out (digital) questionnaires. 3) Not agreeing to participate in the evaluations and/or to the use of the related data, and/or to sign for informed consent to use the data from the Goings-On app for this study.

Design outcomes

Secondary

Measure	Time frame
As secondary outcomes, we will evaluate the symptoms and personal life goals recorded in the Goings-On app, the frequency and extent of the use of the app by brain tumor patients and their characteristics; as well as the usage of the dashboard by the clinical team, for which patients they use the dashboard, and draw a comparison of the characteristics of the patients for which they use it more versus less.	—

Measure

Time frame

As secondary outcomes, we will evaluate the symptoms and personal life goals recorded in the Goings-On app, the frequency and extent of the use of the app by brain tumor patients and their characteristics; as well as the usage of the dashboard by the clinical team, for which patients they use the dashboard, and draw a comparison of the characteristics of the patients for which they use it more versus less.

—

Primary

Measure	Time frame
We will evaluate differences in measures of shared decision-making, aspects of quality of life, and symptoms of anxiety and depression in patients after the implementation of the Goings-On app as compared to the baseline. Furthermore, we will audiotape the first neurosurgical consultation (and the first neuro-oncological consultation will also be audiotaped for most glioma patients) to evaluate differences in content of information discussed and duration of the consultation after the implementation of the Goings-On app as compared to the baseline.	—

Measure

Time frame

We will evaluate differences in measures of shared decision-making, aspects of quality of life, and symptoms of anxiety and depression in patients after the implementation of the Goings-On app as compared to the baseline. Furthermore, we will audiotape the first neurosurgical consultation (and the first neuro-oncological consultation will also be audiotaped for most glioma patients) to evaluate differences in content of information discussed and duration of the consultation after the implementation of the Goings-On app as compared to the baseline.

—

Contacts

Public ContactKarin Gehring

Elisabeth-TweeSteden Ziekenhuis

k.gehring@tilburguniversity.edu+31685242261

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)